Table 2.
Baseline outcome measurement of participants
| Variables | Mean (SD) |
Test statistic | df | P value | |
| Intervention | Control | ||||
| QOL measured by FACT-Ga | |||||
| Physical well-being | 20.24 (5.48) | 20.63 (5.49) | −0.439 | 157 | 0.661 |
| Social well-being | 23.41 (6.47) | 23.63 (7.15) | −0.208 | 153 | 0.836 |
| Emotional well-being | 17.72 (4.13) | 17.21 (4.99) | 0.689 | 156 | 0.492 |
| Functional well-being | 17.42 (5.73) | 17.81 (6.06) | −0.420 | 157 | 0.675 |
| Total QOL | 78.93 (16.16) | 79.21 (18.21) | −0.103 | 150 | 0.918 |
| Fatigue measured by FACT-Fa | |||||
| Fatigue | 33.35 (11.45) | 33.09 (11.57) | 0.141 | 158 | 0.888 |
| Mood status measured by POMSb | |||||
| Tension and anxiety | 10.23 (7.02) | 11.20 (7.39) | −0.826 | 150 | 0.410 |
| Depression | 9.33 (9.99) | 12.32 (12.87) | −1.555 | 142 | 0.122 |
| Anger and hostility | 7.55 (6.92) | 10.07 (9.38) | −1.826 | 141 | 0.070 |
| Lack of vigour | 18.34 (6.87) | 16.55 (6.92) | 1.585 | 147 | 0.115 |
| Fatigue | 10.10 (6.66) | 10.15 (7.01) | −0.052 | 149 | 0.959 |
| Confusion | 7.75 (5.51) | 8.21 (5.93) | −0.494 | 151 | 0.622 |
| Total mood status | 62.85 (35.43) | 68.34 (41.75) | −0.813 | 129 | 0.418 |
| Inflammation | |||||
| C-reactive protein (mg/l) | 9.90 (23.78) | 12.25 (25.71) | −0.503 | 110 | 0.616 |
a
A higher score reflects a positive effect.
b
A lower score reflects a positive effect.
SD, standard deviation; QOL, quality of life; FACT-G, Functional Assessment of Cancer Therapy—General; FACT-F, Functional Assessment of Cancer Therapy—Fatigue; POMS, Profile of Mood State.